← Back to Search

Atorvastatin for COVID-19 (STATCO19 Trial)

Phase 2
Waitlist Available
Led By Lin H Chen, MD
Research Sponsored by Mount Auburn Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient aged 18-85 years, admitted with suspected COVID-19 disease based on clinical criteria (typical upper respiratory symptoms, e.g. runny nose, sore throat, dry cough, associated with COVID-19 infection).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

STATCO19 Trial Summary

This trial looks at whether adding atorvastatin to the usual treatment for COVID-19 can improve clinical outcome in hospitalized patients.

Eligible Conditions
  • COVID-19
  • Coronavirus

STATCO19 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

STATCO19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients that progress to severe or critical requiring ICU admission and/or emergency salvage therapy, or death
Secondary outcome measures
Overall score of patients in each arm on Day 30 based on WHO Ordinal Scale for Clinical Improvement
Overall score of patients in each arm on Day 7 based on WHO Ordinal Scale for Clinical Improvement
Proportions of patients in each arm who test negative for SARS-CoV-2 on Day 7

Side effects data

From 2014 Phase 3 trial • 58 Patients • NCT02084069
3%
Postoperative bleeding
100%
80%
60%
40%
20%
0%
Study treatment Arm
Treatment
Control

STATCO19 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
40 mg
Group II: ControlActive Control1 Intervention
Standard care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Atorvastatin
FDA approved

Find a Location

Who is running the clinical trial?

Mount Auburn HospitalLead Sponsor
3 Previous Clinical Trials
25,068 Total Patients Enrolled
Lin H Chen, MDPrincipal InvestigatorMount Auburn Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~63 spots leftby Mar 2025